APA (7th ed.) Citation

Shu, Y., Cheng, W., He, X., Huang, L., Chen, W., & Zhang, Q. Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024. Elsevier.

Chicago Style (17th ed.) Citation

Shu, Yamin, Wenxin Cheng, Xucheng He, Liu Huang, Wei Chen, and Qilin Zhang. Post-marketing Safety Surveillance for the Recombinant Zoster Vaccine (Shingrix), Vaccine Adverse Event Reporting System, United States, October 2017–April 2024. Elsevier.

MLA (9th ed.) Citation

Shu, Yamin, et al. Post-marketing Safety Surveillance for the Recombinant Zoster Vaccine (Shingrix), Vaccine Adverse Event Reporting System, United States, October 2017–April 2024. Elsevier.